Can't I stop taking Valganciclovir once I take it? Discontinuation precautions and risks

Valganciclovir is an antiviral drug primarily used to treat infections caused by cytomegalovirus (CMV), especially in immunocompromised patients, such as those who have received an organ transplant or have AIDS. Valganciclovir is metabolized in the body and converted into ganciclovir, which works by inhibiting viral DNA synthesis.

Concerning the continuation of valganciclovir medication, there is usually no absolute rule"Once taken, it cannot be stopped", but the formulation of the treatment plan must be based on the patient's specific situation. For high-risk patients, such as those who have received an organ transplant, doctors may recommend continued use of valganciclovir for a period of time after surgery to prevent the occurrence of CMV infection. In this case, discontinuation of the drug may result in a recurrence of the underlying infection, especially if the patient's immune system remains fragile.

During the treatment process, the doctor will regularly evaluate whether the patient needs to continue taking the medication based on the patient's treatment response and side effects. If a patient shows a good response during treatment and has no significant side effects, the doctor may consider tapering the dose or discontinuing the drug. However, the decision to discontinue treatment is usually made after careful evaluation, aiming to balance the effectiveness of treatment against the potential risk of side effects.

On the other hand, long-term use of valganciclovir may cause some adverse reactions, including bone marrow suppression, abnormal liver function and reproductive system problems. Therefore, in the case of long-term use, patients need regular blood tests and clinical monitoring to ensure safety.

In short, the use and discontinuation of valganciclovir should follow the guidance of a physician and be determined based on the patient's specific condition and treatment response. Patients should maintain good communication with their doctors during the treatment process, and any questions or discomforts about medication should be consulted by their doctors in a timely manner so that appropriate adjustments and management can be made.

Reference materials:https://go.drugbank.com/drugs/DB01610